PT  - JOURNAL ARTICLE
AU  - R A Sturge
AU  - J T Scott
AU  - E B Hamilton
AU  - S P Liyanage
AU  - A S Dixon
AU  - J Davies
AU  - C Engler
TI  - Multicentre trial of naproxen and phenylbutazone in acute gout.
AID  - 10.1136/ard.36.1.80
DP  - 1977 Feb 01
TA  - Annals of the Rheumatic Diseases
PG  - 80--82
VI  - 36
IP  - 1
4099  - http://ard.bmj.com/content/36/1/80.short
4100  - http://ard.bmj.com/content/36/1/80.full
SO  - Ann Rheum Dis1977 Feb 01; 36
AB  - Naproxen 750 mg as a single dose followed by 250 mg three times daily has been compared with phenylbutazone 200 mg four times daily for 48 hours followed by 200 mg three times daily for treatment of acute gout in an open study on 41 patients. The drugs were equally effective with few and relatively mild side effects. Naproxen is a useful alternative agent for the treatment of acute gout.